O'Shaughnessy Asset Management’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $2.04M | Buy |
131,722
+975
| +0.7% | +$15.1K | 0.01% | 765 |
|
2025
Q1 | $1.94M | Buy |
130,747
+41,192
| +46% | +$613K | 0.02% | 699 |
|
2024
Q4 | $1.19M | Sell |
89,555
-14,628
| -14% | -$194K | 0.01% | 882 |
|
2024
Q3 | $1.49M | Buy |
104,183
+41,875
| +67% | +$600K | 0.01% | 752 |
|
2024
Q2 | $806K | Sell |
62,308
-26,355
| -30% | -$341K | 0.01% | 929 |
|
2024
Q1 | $1.23M | Buy |
88,663
+26,735
| +43% | +$371K | 0.01% | 744 |
|
2023
Q4 | $884K | Sell |
61,928
-20,561
| -25% | -$293K | 0.01% | 799 |
|
2023
Q3 | $1.28M | Buy |
82,489
+8,671
| +12% | +$134K | 0.02% | 607 |
|
2023
Q2 | $1.16M | Buy |
73,818
+4,729
| +7% | +$74.3K | 0.02% | 602 |
|
2023
Q1 | $1.14M | Sell |
69,089
-64,930
| -48% | -$1.07M | 0.02% | 607 |
|
2022
Q4 | $2.09M | Sell |
134,019
-20,364
| -13% | -$318K | 0.03% | 421 |
|
2022
Q3 | $2M | Sell |
154,383
-7,214
| -4% | -$93.5K | 0.04% | 392 |
|
2022
Q2 | $2.27M | Sell |
161,597
-33,561
| -17% | -$471K | 0.04% | 356 |
|
2022
Q1 | $2.8M | Buy |
195,158
+94,217
| +93% | +$1.35M | 0.05% | 330 |
|
2021
Q4 | $1.38M | Sell |
100,941
-9,787
| -9% | -$133K | 0.02% | 438 |
|
2021
Q3 | $1.81M | Buy |
110,728
+57,621
| +108% | +$944K | 0.04% | 332 |
|
2021
Q2 | $894K | Buy |
53,107
+20,184
| +61% | +$340K | 0.02% | 499 |
|
2021
Q1 | $601K | Buy |
32,923
+9,852
| +43% | +$180K | 0.01% | 544 |
|
2020
Q4 | $420K | Sell |
23,071
-846
| -4% | -$15.4K | 0.01% | 571 |
|
2020
Q3 | $427K | Buy |
23,917
+1,705
| +8% | +$30.4K | 0.01% | 481 |
|
2020
Q2 | $398K | Buy |
22,212
+18,067
| +436% | +$324K | 0.01% | 456 |
|
2020
Q1 | $63K | Sell |
4,145
-2,235
| -35% | -$34K | ﹤0.01% | 730 |
|
2019
Q4 | $126K | Buy |
6,380
+6,372
| +79,650% | +$126K | ﹤0.01% | 733 |
|
2019
Q3 | $0 | Buy |
+8
| New | – | ﹤0.01% | 1232 |
|